Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

MicroPort CRM clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Portugal, France, Spain, Germany, Netherlands, Belgium, Austria, Italy and UK registers with MicroPort CRM as lead sponsor. Synced 12 Nov 2026
4Current trials
3Recruiting now
0Drugs in these trials
9Trial registers
At a glance

MicroPort CRM is the lead sponsor of 4 current clinical trials in our Portugal, France, Spain, Germany, Netherlands, Belgium, Austria, Italy and UK registers. 3 are recruiting patients now. The most common phase is Observational. The most-studied condition is Bradycardia.

ClinicalTrials.gov trials by status

  • Recruiting375%
  • Active, closed125%

Trials by phase

  • Observational250%
  • Not applicable250%
01

Clinical trials sponsored by MicroPort CRM

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers
NCT05165095 · Bradycardia, Remote Monitoring
Observational Recruiting 2022-03 UK, Germany, France, Spain, Netherlands, Belgium, Austria, Portugal
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
NCT07342608 · ClinicalTrials.gov ↗ · Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
Not applicable Recruiting 2026-06 France, Spain, Italy, Belgium, Portugal
Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices
NCT05694572 · ClinicalTrials.gov ↗ · Cardiac Rhythm Disorder, Heart Failure, Sudden Cardiac Death
Observational Recruiting 2023-10 Portugal
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641 · ClinicalTrials.gov ↗ · Heart Failure, Cardiac Resynchronization Therapy
Not applicable Active, closed 2020-12 Germany, France, Spain, Italy, Netherlands, Austria, Portugal

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in MicroPort CRM trials

8 conditions
Bradycardia2Heart Failure2Remote Monitoring1Cardiac Resynchronization Therapy1Left Bundle Branch Area Pacing1Left Bundle Branch Pacing1Cardiac Rhythm Disorder1Sudden Cardiac Death1
05

Questions about MicroPort CRM trials

How many clinical trials does MicroPort CRM sponsor?

MicroPort CRM is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Portugal, France, Spain, Germany, Netherlands, Belgium, Austria, Italy and UK registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are MicroPort CRM trials recruiting?

Yes. 3 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.